Results

Total Results: 1,474 records

Showing results for "children/adolescents".

1. Children/Adolescents | Agency for Healthcare Research and Quality
   www.ahrq.gov/topics/childrenadolescents.html
   January 01, 2011 - Topic: Children/Adolescents Background Report for the Request for Public Comment on Initial, Recommended Core Set of Children's Healthcare Quality Measures for Voluntary Use by Medicaid and CHIP Programs CAHPS Child Hospital Survey (Child HCAHPS) Toolkit Cente…

2. Antipsychotic Medications in Children and Adolescents Toolkit (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/toolkits/antipsychotics-toolkit.pdf
   June 01, 2020 - Antipsychotic Medications in Children and Adolescents Toolkit Pediatric Quality Measures Program Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit 2 ACKNOWLEDGEMENTS ................................................................................ 3 …

3. Metabolic Monitoring for Children and Adolescents on Antipsychotics (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-150-fullreport.pdf
   February 14, 2018 - Metabolic Monitoring for Children and Adolescents on Antipsychotics 1 Metabolic Monitoring for Children and Adolescents on Antipsychotics Section 1. Basic Measure Information 1.A. Measure Name Metabolic Monitoring for Children and Adolescents on Antipsychotics 1.B. Measure Number 0150 1.C. Measure Descripti…

4. Metabolic Monitoring for Children and Adolescents on Antipsychotics | Agency for Healthcare Research and Quality
   www.ahrq.gov/pqmp/measures/metabolic-monitoring-antipsychotics.html
   August 01, 2021 - Metabolic Monitoring for Children and Adolescents on Antipsychotics Measure Domain:  Management of Chronic Conditions Measure Sub-Domain:  Use of Antipsychotics Subcategory: Safe and judicious antipsychotic use in children and adolescents PQMP COE:  NCINQ Associated NQF # and Name:  2800, Metabolic Monitoring …

5. Metabolic Screening for Children and Adolescents Newly on Antipsychotics (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-149-fullreport.pdf
   February 01, 2019 - Metabolic Screening for Children and Adolescents Newly on Antipsychotics 1 Metabolic Screening for Children and Adolescents Newly on Antipsychotics Section 1. Basic Measure Information 1.A. Measure Name Metabolic Screening for Children and Adolescents Newly on Antipsychotics 1.B. Measure Number 0149 1.C. Me…

6. Follow-Up Visit for Children and Adolescents on Antipsychotics (pdf file)
   www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-147-fullreport.pdf
   February 01, 2019 - Follow-Up Visit for Children and Adolescents on Antipsychotics 1 Follow-up Visit for Children and Adolescents on Antipsychotics Section 1. Basic Measure Information 1.A. Measure Name Follow-up Visit for Children and Adolescents on Antipsychotics 1.B. Measure Number 0147 1.C. Measure Description Please provi…

7. Use of Multiple Concurrent Antipsychotics in Children and Adolescents | Agency for Healthcare Research and Quality
   www.ahrq.gov/pqmp/measures/multiple-concurrent-antipsychotics.html
   August 01, 2021 - Use of Multiple Concurrent Antipsychotics in Children and Adolescents Measure Domain:  Management of Chronic Conditions Measure Sub-Domain:  Use of Antipsychotics Subcategory:  Safe and judicious antipsychotic use in children and adolescents PQMP COE:  NCINQ Associated NQF # and Name:  None Products: Fact She…

8. Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics | Agency for Healthcare Research and Quality
   www.ahrq.gov/pqmp/measures/first-line-psychosocial-care-antipsychotics.html
   August 01, 2021 - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics Measure Domain:  Management of Chronic Conditions Measure Sub-Domain:  Use of Antipsychotics Subcategory:  Safe and judicious antipsychotic use in children and adolescents PQMP COE:  NCINQ Associated NQF # and Name:  2801, Use of…

9. Children/adolescents admitted to the hospital with psychotic symptoms who are not currently taking antipsychotics | Agency for Healthcare Research and Quality
   www.ahrq.gov/pqmp/measures/adolescents-antipsychotic-medications.html
   August 01, 2021 - Children/adolescents admitted to the hospital with psychotic symptoms who are not currently taking antipsychotics Measure Domain:  Management of Acute Conditions Measure Sub-Domain:  Pediatric Psychosis PQMP COE:  COE4CCN Associated NQF # and Name:  None Products: Fact Sheet: None. Full Report: None. Meas…

10. Measures To Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-testing-summary.pdf
    February 22, 2019 - Measures To Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary 1 National Collaborative for Innovation in Quality Measurement (NCINQ) Measures to Assess the Safe and Judicious Use of Antipsychotics in Children and Adolescents Field Test Summary This report sum…

11. Children/adolescents admitted to the hospital with a diagnosis of psychotic disorder should have documentation in their medical record of a baseline metabolic | Agency for Healthcare Research and Quality
    www.ahrq.gov/pqmp/measures/adolescents-psychotic-disorder.html
    August 01, 2021 - Children/adolescents admitted to the hospital with a diagnosis of psychotic disorder should have documentation in their medical record of a baseline metabolic Measure Domain:  Management of Acute Conditions Measure Sub-Domain:  Pediatric Psychosis PQMP COE:  COE4CCN Associated NQF # and Name:  None Products: …

12. Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit | Agency for Healthcare Research and Quality
    www.ahrq.gov/pqmp/implementation-qi/toolkit/antipsychotic/index.html
    July 01, 2021 - Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit Next Page Table of Contents Safe and Judicious Use of Antipsychotic Medications in Children and Adolescents Toolkit Introduction Overview About the Measure Key Driver Diagrams Quality Improvement Strategi…

13. Prevalence of Abnormal Lipid Levels in Children and Adolescents | Agency for Healthcare Research and Quality
    www.ahrq.gov/data/visualizations/prevalence-fh-mfd.html
    October 01, 2023 - Prevalence of Abnormal Lipid Levels in Children and Adolescents This interactive visualization displays the prevalence of abnormal lipid levels among cohorts of children. The prevalence data can be filtered by the condition of interest (familial hypercholesterolemia or multifactorial dyslipidemia), type of li…

14. Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/chipra_1415-p011-1-ef_0.pdf
    March 01, 2015 - Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents Measures: Safe and Judicious Antipsychotic Use in Children and Adolescents Measure Developer: National Collaborative for Innovation in Quality Measurement As part of the Pediatric Quality Measures Program (PQMP), the Agency for Healthcare R…

15. Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-fullreport.pdf
    February 01, 2019 - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics 1 Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics Section 1. Basic Measure Information 1.A. Measure Name Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics 1.B.…

16. Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-fullreport.pdf
    May 01, 2018 - Use of Higher-Than-Recommended Doses of Antipsychotics in Children and Adolescents 1 Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents Section 1. Basic Measure Information 1.A. Measure Name Use of Higher-than-Recommended Doses of Antipsychotics in Children and Adolescents 1.B.…

17. Section 3. Recommendations for Children and Adolescents | Agency for Healthcare Research and Quality
    www.ahrq.gov/prevention/guidelines/guide/section3.html
    June 01, 2014 - Guide to Clinical Preventive Services, 2014 Section 3. Recommendations for Children and Adolescents Previous Page Next Page Table of Contents Guide to Clinical Preventive Services, 2014 Foreword Appendix E: More Resources Appendix D. About the U.S. Preventive Services Task Force Appendix C: …

18. Children/adolescents admitted to the hospital with psychotic symptoms should have a psychiatric consult (in person or tele-psychiatry) within 24 hours of admission | Agency for Healthcare Research and Quality
    www.ahrq.gov/pqmp/measures/adolescents-psychiatric-consult.html
    August 01, 2021 - Children/adolescents admitted to the hospital with psychotic symptoms should have a psychiatric consult (in person or tele-psychiatry) within 24 hours of admission Measure Domain:  Management of Acute Conditions Measure Sub-Domain:  Pediatric Psychosis PQMP COE:  COE4CCN Associated NQF # and Name:  None Measu…

19. Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) (pdf file)
    www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-148-section-2-tech-specs.pdf
    February 22, 2019 - Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP) Use of First-Line Psychosocial Care for Children and Adolescents on Antipsychotics (APP)* *Developed with financial support from the Agency for Healthcare Research and Quality (AHRQ) and CMS under the CHIPRA Pediatric …

20. Metabolic Screening for Children and Adolescents Newly on Antipsychotics | Agency for Healthcare Research and Quality
    www.ahrq.gov/pqmp/measures/metabolic-screening-antipsychotics.html
    August 01, 2021 - Metabolic Screening for Children and Adolescents Newly on Antipsychotics Measure Domain:  Management of Chronic Conditions Measure Sub-Domain:  Use of Antipsychotics PQMP COE:  NCINQ Associated NQF # and Name:  None Products: Fact Sheet  (PDF, 315 KB) Full Report: In preparation for posting—available upon re…